Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach

BACKGROUND: Outbreak of COVID-19 has been recognized as a global health concern since it causes high rates of morbidity and mortality. No specific antiviral drugs are available for the treatment of COVID-19 till date. Drug repurposing strategy helps to find out the drugs for COVID-19 treatment from...

Descripción completa

Detalles Bibliográficos
Autores principales: Indu, Purushothaman, Rameshkumar, Marimuthu Ragavan, Arunagirinathan, Narasingam, Al-Dhabi, Naif Abdullah, Valan Arasu, Mariadhas, Ignacimuthu, Savarimuthu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587076/
https://www.ncbi.nlm.nih.gov/pubmed/33168456
http://dx.doi.org/10.1016/j.jiph.2020.10.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587076/
https://www.ncbi.nlm.nih.gov/pubmed/33168456
http://dx.doi.org/10.1016/j.jiph.2020.10.015

Ejemplares similares